Eltrombopag

Details

Files

Generic Name:

Eltrombopag

Project Status:

Complete

Therapeutic Area:

Thrombocytopenia associated with chronic hepatitis c infection

Manufacturer:

GlaxoSmithKline

Call for patient/clinician input open:

July 9, 2014

Brand Name:

Revolade

Project Line:

Reimbursement Review

Project Number:

SR0377-000

Call for patient/clinician input closed:

August 28, 2014

NOC Status at Filing:

Post NOC

Performance Metric:

N/A — Predated performance metrics

Submission Type:

Initial

Indications:

Thrombocytopenia associated with chronic hepatitis c infection

Recommendation Type:

List with criteria/condition

Final Recommendation:

March 18, 2015

Last Updated : March 31, 2014